Over 10 million people will face a hosepipe ban after Thames Water became the latest water company to announce usage restrictions - as the Environment Agency (EA) warns much of England is at risk of drought.
GM's Q2 earnings beat estimates as strong pricing, lower costs and disciplined incentives drive margin gains and a higher 2026 outlook.
MAMA is betting on new products, packaging and protein formats to expand retail reach as launch costs pressure margins.
Navitas Semiconductor is shifting toward AI infrastructure, with growing demand for GaN and SiC power chips supporting its long-term growth outlook.
Morpho has officially launched its fixed-rate lending protocol Midnight on Base, adding a new credit layer to its onchain lending network as it seeks to bring fixed-rate, fixed-term borrowing closer to traditional financial markets.
Novo Nordisk (NYSE:NVO) has filed a federal lawsuit against Eli Lilly, alleging that its rival's advertising campaigns for blockbuster GLP-1 obesity and diabetes drugs mislead consumers about the effectiveness of competing treatments. The complaint, filed on July 21, 2026, in the US District Court for the District of New Jersey, challenges nationwide advertisements for Lilly's Zepbound and Mounjaro that Novo claims rely on outdated clinical trial data and create an inaccurate comparison between the companies' medicines.
CRM's faster AI growth, stronger earnings revisions and lower valuation give it a slight edge over ADBE in enterprise software.
Amid macroeconomic volatility, steady global connectivity bodes well for Zacks Satellite and Communication industry participants, such as GILT, TSAT and SATL.
RTX heads into Q2 earnings with forecasts for revenue and EPS growth, backed by aerospace demand, defense momentum and a strong backlog.
LLY's leadership in obesity drugs, expanding pipeline and stronger growth outlook set it apart as investors weigh it against NVO in 2026.
MercadoLibre's credit card flywheel is accelerating as issuance, balances and payment volume surge, while credit quality improves.
Dyne gains momentum as FDA priority review for its lead DMD therapy and progress in its DM1 program strengthen confidence in its pipeline.
Euro slips as Middle East tensions boost the US Dollar despite upbeat ZEW surveys
The CLARITY Act faces a late-July Senate deadline. Here's what passage or failure means for XRP, altcoins, and the broader crypto regulatory XRP holders face a July 23 deadline on the CLARITY Act.
XRP has broken free from a 66-day downtrend, decisively clearing key resistance as bullish momentum accelerates, with analysts eyeing $1.30 and a strengthening triple-bottom pattern signaling further upside.
Viper Energy offers a compelling royalty model, strong cash flow, and shareholder-friendly capital returns, but current valuation limits its appeal. VNOM trades at 17x forward earnings with a 5%+ yield, but peers like Black Stone Minerals and Dorchester Minerals offer higher yields and cheaper multiples. Recent asset sales improved VNOM's balance sheet, enabling debt reduction, dividend hikes, and aggressive buybacks, but production growth appears well priced in.
INTC's Q2 results could get a lift from stronger processor sales as AI PCs, new chip launches and enterprise refresh trends support client computing.
ALLE heads into Q2 results with revenue and earnings growth expected as acquisitions and international demand face cost and FX pressures.
INTC's Q2 earnings may get support from stronger data center and AI revenues as Xeon demand, AI infrastructure and hyperscaler deals fuel growth.
ATRO, IX and FLNC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 21, 2026.
West Coast Community Bancorp (WCCB) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.23 per share a year ago.
The Strike founder is leaving the Tether-controlled treasury company after a board disagreement, as a proposed three-way merger with Strike and Elektron Energy collapses.
General Motors (GM) shares are inching higher on Tuesday morning after the automaker posted a powerhouse Q2 earnings release, outperforming Street expectations across key operational metrics Revenue came in just over $48 billion – reflecting a 1.9% year-over-year increase – while adjusted earnings per share went up 41.3% versus last year to $3.57 in the second quarter. Driven by North American truck demand, resilient pricing power, and strict discipline on operating overhead, GM raised its full-year adjusted profit and free cash flow guidance for the second time this year.
UPS heads into Q2 earnings with lower volumes, rising per-piece revenues and cost cuts shaping profitability as investors await updated guidance.
FSI's Q2 revenues fall 35% due to recognition of one-time R&D income in the year-ago quarter, lower Florida sales and deliveries shifting to Q3.
Nuvation Bio (NUVB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NOC beats Q2 earnings and sales estimates, raises its 2026 outlook and ends the quarter with a $95.68 billion backlog.
The number that stops investors cold when they look at the Putnam BDC Income ETF (NYSEARCA:PBDC) is 13.49%.
HSAI gets the edge over OUST as profitability, automotive lidar leadership, global partnerships and a cheaper valuation outweigh Ouster's rally.
Boeing (BA) demonstrated stable net order inflow in June, booking 113 net orders valued at $7.3 billion, with strong single-aisle demand. BA's delivery cadence is improving, with 64 aircraft delivered in June and year-to-date deliveries up 12%, reflecting more sustainable, output-based production. Key operational milestones include ramping up 737 MAX and 787 production, inaugurating a fourth 737 MAX line, and progressing on MAX 7, MAX 10, and 777X certifications.